{"Title": "Quetiapine and the development of the metabolic syndrome", "Year": 2015, "Source": "QJM", "Volume": "108", "Issue": 3, "Art.No": null, "PageStart": 245, "PageEnd": 247, "CitedBy": 2, "DOI": "10.1093/qjmed/hcs142", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84924514079&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Antipsychotic Agents", "Humans", "Male", "Metabolic Syndrome X", "Quetiapine Fumarate", "Schizophrenia", "Young Adult"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-84924514079", "SubjectAreas": [["Medicine (all)", "MEDI", "2700"]], "AuthorData": {"56619014700": {"Name": "Jalota R.", "AuthorID": "56619014700", "AffiliationID": "60024544", "AffiliationName": "University College London Hospital"}, "57198253667": {"Name": "Bond C.", "AuthorID": "57198253667", "AffiliationID": "60024544", "AffiliationName": "University College London Hospital"}, "56304528100": {"Name": "Jos\u00e9 R.J.", "AuthorID": "56304528100", "AffiliationID": "60024544", "AffiliationName": "University College London Hospital"}}}